Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2017-03-01 Tx date 2017-02-24 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
||
Filed 2017-03-01 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,455
-23,500 vol $0.53 each |
-123,500 | |
Filed 2017-03-01 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
||
Filed 2017-03-01 Tx date 2017-02-24 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,520
-23,500 vol $0.32 each |
76,500 | |
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,000
-100,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
-150,000 | |
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,000
-100,000 vol $0.32 each |
100,000 | |
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,000
-100,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-16 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100,000 vol $0.45 each |
||
Filed 2017-02-27 Tx date 2017-02-16 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100,000 vol $0.45 each |
||
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-45,000
-100,000 vol $0.45 each |
-100,000 | |
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
||
Filed 2017-02-27 Tx date 2017-02-24 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
50,000 | |
Filed 2016-11-22 Tx date 2016-11-22 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,000
+50,000 vol $0.34 each |
50,000 | |
Filed 2016-11-22 Tx date 2016-11-22 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,500
-50,000 vol $0.39 each |
0 | |
Filed 2016-11-22 Tx date 2016-08-08 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-30 Tx date 2016-08-08 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-30 Tx date 2016-09-29 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 |